Back to top
more

Abbott Laboratories (ABT)

(Delayed Data from NYSE)

$114.14 USD

114.14
5,785,034

-0.29 (-0.25%)

Updated Aug 20, 2026 04:03 PM ET

After-Market: $114.41 +0.27 (0.24%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.94%
2Buy18.22%
3Hold10.27%
4Sell5.79%
5Strong Sell3.20%
S&P50011.55%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 39% (97 out of 247)

Industry: Medical - Products

Zacks News

Zacks Equity Research

PBH vs. ABT: Which Stock Should Value Investors Buy Now?

PBH vs. ABT: Which Stock Is the Better Value Option?

Zacks Equity Research

Is Trending Stock Abbott Laboratories (ABT) a Buy Now?

Zacks.com users have recently been watching Abbott (ABT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks Equity Research

Why the Market Dipped But Abbott (ABT) Gained Today

The latest trading day saw Abbott (ABT) settling at $128.47, representing a +2.4% change from its previous close.

Zacks Equity Research

Abbott Gains From Lingo CGM's Expansion on Android Platform

ABT expands its Lingo biowearable to Android, broadening access to real-time glucose tracking and pushing continuous monitoring into mainstream wellness.

Moumi Mondal headshot

What Is Driving Hologic's Strength in the US Diagnostics Market?

HOLX's Diagnostics gains accelerate as U.S. molecular testing drives growth and new Panther Fusion and Genius platform approvals widen its runway.

Moumi Mondal headshot

Boston Scientific Sustains Momentum in the PFA Market: What's Next?

BSX builds momentum in PFA as FARAPULSE posts strong growth, and new trial results and expanded FDA labeling boost its AF treatment push.

Zacks Equity Research

Here's Why Abbott (ABT) Fell More Than Broader Market

In the latest trading session, Abbott (ABT) closed at $122.09, marking a -2.39% move from the previous day.

Moumi Mondal headshot

HOLX Stock Up 16% in 6 Months: Is it Still a Hold Heading Into 2026?

Hologic shares rise 16% in six months, with divisional strength clinical data and a go-private deal shaping the short-term outlook.

Zacks Equity Research

The Zacks Analyst Blog Highlights HSBC, Abbott, Shell and Oak Valley

HSBC, Abbott, Shell and Oak Valley feature in the latest Zacks Analyst Blog as analysts highlight operational resilience, strategic pivots and industry-specific challenges.

Mark Vickery headshot

Top Analyst Reports for HSBC, Abbott & Shell

HSBC's Asia pivot, Abbott's device momentum and Shell's resilient Q3 results headline today's standout analyst reports.